1-158672135-T-G
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_003126.4(SPTA1):c.1412A>C(p.Gln471Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000014   (  0   hom.  ) 
Consequence
 SPTA1
NM_003126.4 missense
NM_003126.4 missense
Scores
 3
 10
 6
Clinical Significance
Conservation
 PhyloP100:  7.42  
Publications
3 publications found 
Genes affected
 SPTA1  (HGNC:11272):  (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017] 
SPTA1 Gene-Disease associations (from GenCC):
- hereditary spherocytosis type 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
 - elliptocytosis 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
 - pyropoikilocytosis, hereditaryInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - hereditary elliptocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - hereditary spherocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
PP3
MetaRNN computational evidence supports a deleterious effect, 0.974
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00000657  AC: 1AN: 152242Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
152242
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000401  AC: 1AN: 249268 AF XY:  0.00   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
249268
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000137  AC: 2AN: 1461756Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 727180 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2
AN: 
1461756
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
0
AN XY: 
727180
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
33468
American (AMR) 
 AF: 
AC: 
0
AN: 
44704
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26130
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39684
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53402
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111954
Other (OTH) 
 AF: 
AC: 
0
AN: 
60392
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00000657  AC: 1AN: 152242Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74382 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
152242
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
0
AN XY: 
74382
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41466
American (AMR) 
 AF: 
AC: 
0
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5202
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68040
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Uncertain significance 
Submissions summary: Pathogenic:1Uncertain:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Elliptocytosis 2    Pathogenic:1 
Oct 01, 1989
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
not provided    Uncertain:1 
Dec 21, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Uncertain 
D 
 BayesDel_noAF 
 Uncertain 
 DANN 
 Uncertain 
 DEOGEN2 
 Uncertain 
D;D 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Benign 
.;T 
 M_CAP 
 Benign 
D 
 MetaRNN 
 Pathogenic 
D;D 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Uncertain 
M;M 
 PhyloP100 
 PrimateAI 
 Benign 
T 
 PROVEAN 
 Uncertain 
D;. 
 REVEL 
 Uncertain 
 Sift 
 Benign 
T;. 
 Sift4G 
 Uncertain 
D;. 
 Polyphen 
D;D 
 Vest4 
 MutPred 
Loss of helix (P = 0.2271);Loss of helix (P = 0.2271);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.